GlobeNewswire
-
Capilea Mexico Unveils New Insights on Surge of US Patients Choosing Mexico for Hair Transplants
26/12/2025 -
Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations
26/12/2025 -
Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources
26/12/2025 -
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
26/12/2025 -
Can-Fite Granted Brazilian Patent for Treatment of Sexual Dysfunction
26/12/2025 -
IBA signs contract for a three-room Proteus®PLUS solution to be installed at the Seoul St. Mary’s Hospital
26/12/2025 -
IBA signe un contrat pour l’installation d’une solution Proteus®PLUS à trois salles au Seoul St. Mary’s Hospital
26/12/2025 -
XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
24/12/2025 -
LULUTOX Detox Tea in Consumer Coverage as Website Update Introduces More Transparency in Herbal Digestive Supplement Information
24/12/2025 -
Relapse Risk Increases During the Holidays; Desert Hope Treatment Center Urges Early Support
24/12/2025 -
Human Appeal launches e-greeting card collection to support emergency charity projects
24/12/2025 -
DXS International plc (AQSE: DXSP) Update on Cyber Security Incident
24/12/2025 -
Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
24/12/2025 -
Communiqué de presse : Sanofi va acquérir Dynavax et ajouter un vaccin commercialisé contre l’hépatite B pour adultes et un candidat vaccin de phase 1⁄2 contre le zona au pipeline
24/12/2025 -
Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
24/12/2025 -
Communiqué de presse : Sanofi fait le point sur la soumission réglementaire du tolebrutinib dans la sclérose en plaques secondaire progressive non-récurrente
24/12/2025 -
Best Peptides for Muscle Growth: Prescription Sermorelin Access, Injectable vs. Dissolving Tablets, and Realistic Expectations
24/12/2025 -
U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
24/12/2025 -
Best BPC-157 Oral Supplements: ProHealth's Triple-Tested Formula Examined as Peptide Quality Verification Becomes Consumer Priority Heading Into 2026
24/12/2025
Pages